A Murine experimental models in carcinogenesis studies are efficient?
DOI:
https://doi.org/10.31686/ijier.vol8.iss1.2153Keywords:
Neoplasms, Immunology, Neoplasm Transplantation, OncogenesisAbstract
Economic and social development has essential repercussions on the health of populations, as it alters the morbidity and mortality profile and favors the increase in exposures and risks to human health, especially the risk of cancer. Cancer is considered a significant public health problem worldwide, and remains with high incidence rates, being considered a complex disease, with multifactorial causes. The permanent incidence rates of prostate cancer prove to be one of the most prevalent, considered the second most common cancer in men worldwide, and a leading cause of deaths from chronic noncommunicable diseases. Among the different types of cancer, prostate cancer has been the subject of great scientific interest. In this context, animal models are valuable for studying cancer-related aspects, the use of animal models has the potential to increase our understanding of carcinogenesis, tumor biology, and the impact of specific molecular events on tumor biology. Animal models with specific human cancer characteristics can be used to test cancer prevention and treatment strategies. In this review, we aim to show how the use of animal models as an essential tool in the study of the molecular mechanisms of carcinogenesis.
References
[1]. R.L. Siegel, K.D. Miller, A. Jemal. Cancer statistics, CA Cancer J Clin. 2018. v. 68, p.7-30. doi: 10.3322/caac.21551
[2]. BRASIL. Ministério da Saúde. Secretaria de Assistência à Saúde. Instituto Nacional de Câncer. Programa nacional de controle do câncer de colonrretal: documento de consenso. - Rio de Janeiro. INCA, 2018.
[3]. World Health Organization, Global Action plan for the prevention and control of noncommunicable diaseases 2013-2020. 2013
[4]. G.A.S. Mendonça. Câncer na população feminina brasileira. Rev. Saúde Pública. 1993. v. 27, n.1, p.68-75. http://dx.doi.org/10.1590/S0034-89101993000100011
[5]. M.R. Guerra, C.V.M. Gallo, G.A.S. Mendonça. Risco de câncer no Brasil: tendências e estudos epidemiológicos mais recentes. Rev. Brasileira de Cancerologia. 2005. v. 5, n.3, p. 227-234. https://pdfs.semanticscholar.org/c4c6/060c4fd66294e1517cff64fabde16dc7b4be.pdf
[6]. M. V. Nunes, E.H. Tajara. Efeitos tardios dos praguicidas organoclorados no homem. Rev. Saúde Pública. 1998 v.32,n. 4, p. 372-384. http://dx.doi.org/10.1590/S0034-89101998000400011
[7]. World Health Organization. Visão Global do Câncer, 2019.
[8]. C.R. Daleck, A.B. De Nardi. Oncologia Em Cães e Gatos - 2ª Ed. Rio de janeiro: Roca; 2016.
[9]. P.D.S. Quijada, P.A. Fernandes, D.S. Oliveira, B.M.O. Santos.Câncer de próstata: retrato de uma realidade de pacientes em tratamento. Rev enferm UFPE on line. 2017. v.11, (Supl. 6), p. 2490-9.
[10]. American Cancer Society. [Internet]. 2015. Disponível em: https://www.cancer.org/es/investigacion/datos-y-estadisticas-sobre-el-cancer-entre-los-hispanos.html. Acesso em: 10 de dez 2019.
[11]. J.S. Araújo, V.M. Conceição, M.M.F. Zago. Masculinidades transitórias no adoecimento pelo câncer de próstata. Rev. Latino-Am. Enfermagem. 2019. v. 27, n. 3224, p.1-9. http://dx.doi.org/10.1590/1518-8345.3248.3224
[12]. L.J. James, G.Wong, J.C.Craig, C.S. Hanson, A. Ju, K. Howard. Men’s perspectives of prostate cancer screening: A systematic review of qualitative studies. PLoS One. 2017. v.12, n.11, p. 1-23. DOI: 10.1371/journal.pone.0188258
[13]. A.E. Romanzini, M.G. Pereira, C. Guilherme, A.J. Cologna, E.C. Carvalho. Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study. Rev. Latino-Am. Enfermagem. 2018. v. 26, n. 3031, p.1-14. http://dx.doi.org/10.1590/1518-8345.2601.3031
[14]. J.G. Clohessy, P.P. Pandolfi. Mouse hospital andco-clinical trialp roject—from bench to bed side .Nat. Rev. Clin. Oncol. 2015. 12, 491–498. doi: 10.1038/nrclinonc.2015.62
[15]. M.M. Grabowska, D.J. DeGraff, X. Yu, R.J. Jin, Z. Chen, A.D. Borowsky, R.J. Matusik. Mouse Models of Prostate Cancer: Picking the Best Model for the Question. Cancer Metastasis Rev. 2014 September ; 33(0): 377–397. doi:10.1007/s10555-013-9487-8. doi: 10.1007/s10555-013-9487-8
[16]. R.L.Johnson, J.C. Fleet. Animal Models of corectal Cancer. Cancer Metastasis Rev. 2013. v.32, n. 0, p. 39-67. doi: 10.1007/s10555-012-9404-6.
[17]. G.P. Dunn, L.J. Old, R.D. Schreiber. The immunobiology of cancer immune surveillance and immune editing. Immunity. 2004. v.21, n. 2, p. 137-48. https://doi.org/10.1016/j.immuni.2004.07.017
[18]. C. Pantaleão, A. Luchs. Câncer e modelos experimentais de tumores murinos. Ver Inst Adolfo Lutz. 2010. V. 69, n. 4, p. 439-45. http://periodicos.ses.sp.bvs.br/scielo.php?script=sci_arttext&pid=S0073-98552010000400001&lng=pt&nrm=iso
[19]. N. Sengupta, T.S. MacFie, T.T. MacDonald, D. Pennington, A.R. Silver. Cancer immuno editing and “spontaneus” tumor regression. Pathol Res Pract. 2010. v. 206, n. 1, p. 1-8.
[20]. S.I. Park, S.J. Kimm, L.K. McCauley, G.E. Gallick. Pre-Clinical Mouse Models of Human Prostate Cancer and their Utility in Drug Discovery. Curr Protoc Pharmacol. 2010 December 1; 51: 14.15–14.15.27. doi:10.1002/0471141755.ph1415s51.
[21]. M. Ittmann, J. Huang, E. Radaelli, P.Martin, S. Signoretti, R. Sullivan, B.W. Simons, J.M. Ward, B.D. Robinson, G.C. Chu, M. Loda, G. Thomas, A. Borowsky, R.D. Cardiff. Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Research Online. 2013. v.73, n. 9, p. 2718-3. disponívelem: https://cancerres.aacrjournals.org/content/73/9/2718.full-text.pdf
[22]. M.M. Shen, C. abate-shen. molecular genetics of prostate câncer: new prospects for old challenges. Genes dev. 2010. doi: 10.1101/gad.1965810.
[23]. D. Lin, H. Xue, Y. Wang, R. Wu, A. Watahiki, X. Dong, H. Cheng, A.W.Wyatt, C.C. Collins, P.W. Gout, Y. Wang. Next generation patient-derived prostate cancer xenograft models. Asian J Androl. 2014. v. 16, n. 3, p. 407-412. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023366/
[24]. Y. Wang, J.X. Wang, H. Xue, D. Lin, X. Dong, P.W. Gout, X. Gao, J. Pang. Subrenal capsule grafting technology in human câncer modeling and translational câncer research. Differentiation. 2015. 91:15–19. doi: 10.1016/j.diff.2015.10.012
[25]. N.M Navone, M.E. Labate, P. Troncoso, C.L. Pisters, A.C.V. Eschenbach, C.J. Logothetis. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. O Jornal de Urologia. 1999. v. 161, Edição 1, p. 304-308. PMID: 10037428
[26]. J. Pavese, I.M. Ogden, R.C. Bergan. An Orthotopic Murine Model of Human Prostate Cancer Metastasis. Journal of Visualized Experiments. p.1-9. 2013 doi: 10.3791/50873.
[27]. Y. Huang, C. Cheng, C. Zhang, Y. Zhang, M. Chen, D.W. Strand, M. Jiang. Advances in prostate cancer research models: From transgenic mice to tumor xenografting models. Asian Journal of Urology. 2016. 3:64-74. https://doi.org/10.1016/j.ajur.2016.02.004
[2]. BRASIL. Ministério da Saúde. Secretaria de Assistência à Saúde. Instituto Nacional de Câncer. Programa nacional de controle do câncer de colonrretal: documento de consenso. - Rio de Janeiro. INCA, 2018.
[3]. World Health Organization, Global Action plan for the prevention and control of noncommunicable diaseases 2013-2020. 2013
[4]. G.A.S. Mendonça. Câncer na população feminina brasileira. Rev. Saúde Pública. 1993. v. 27, n.1, p.68-75. http://dx.doi.org/10.1590/S0034-89101993000100011
[5]. M.R. Guerra, C.V.M. Gallo, G.A.S. Mendonça. Risco de câncer no Brasil: tendências e estudos epidemiológicos mais recentes. Rev. Brasileira de Cancerologia. 2005. v. 5, n.3, p. 227-234. https://pdfs.semanticscholar.org/c4c6/060c4fd66294e1517cff64fabde16dc7b4be.pdf
[6]. M. V. Nunes, E.H. Tajara. Efeitos tardios dos praguicidas organoclorados no homem. Rev. Saúde Pública. 1998 v.32,n. 4, p. 372-384. http://dx.doi.org/10.1590/S0034-89101998000400011
[7]. World Health Organization. Visão Global do Câncer, 2019.
[8]. C.R. Daleck, A.B. De Nardi. Oncologia Em Cães e Gatos - 2ª Ed. Rio de janeiro: Roca; 2016.
[9]. P.D.S. Quijada, P.A. Fernandes, D.S. Oliveira, B.M.O. Santos.Câncer de próstata: retrato de uma realidade de pacientes em tratamento. Rev enferm UFPE on line. 2017. v.11, (Supl. 6), p. 2490-9.
[10]. American Cancer Society. [Internet]. 2015. Disponível em: https://www.cancer.org/es/investigacion/datos-y-estadisticas-sobre-el-cancer-entre-los-hispanos.html. Acesso em: 10 de dez 2019.
[11]. J.S. Araújo, V.M. Conceição, M.M.F. Zago. Masculinidades transitórias no adoecimento pelo câncer de próstata. Rev. Latino-Am. Enfermagem. 2019. v. 27, n. 3224, p.1-9. http://dx.doi.org/10.1590/1518-8345.3248.3224
[12]. L.J. James, G.Wong, J.C.Craig, C.S. Hanson, A. Ju, K. Howard. Men’s perspectives of prostate cancer screening: A systematic review of qualitative studies. PLoS One. 2017. v.12, n.11, p. 1-23. DOI: 10.1371/journal.pone.0188258
[13]. A.E. Romanzini, M.G. Pereira, C. Guilherme, A.J. Cologna, E.C. Carvalho. Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study. Rev. Latino-Am. Enfermagem. 2018. v. 26, n. 3031, p.1-14. http://dx.doi.org/10.1590/1518-8345.2601.3031
[14]. J.G. Clohessy, P.P. Pandolfi. Mouse hospital andco-clinical trialp roject—from bench to bed side .Nat. Rev. Clin. Oncol. 2015. 12, 491–498. doi: 10.1038/nrclinonc.2015.62
[15]. M.M. Grabowska, D.J. DeGraff, X. Yu, R.J. Jin, Z. Chen, A.D. Borowsky, R.J. Matusik. Mouse Models of Prostate Cancer: Picking the Best Model for the Question. Cancer Metastasis Rev. 2014 September ; 33(0): 377–397. doi:10.1007/s10555-013-9487-8. doi: 10.1007/s10555-013-9487-8
[16]. R.L.Johnson, J.C. Fleet. Animal Models of corectal Cancer. Cancer Metastasis Rev. 2013. v.32, n. 0, p. 39-67. doi: 10.1007/s10555-012-9404-6.
[17]. G.P. Dunn, L.J. Old, R.D. Schreiber. The immunobiology of cancer immune surveillance and immune editing. Immunity. 2004. v.21, n. 2, p. 137-48. https://doi.org/10.1016/j.immuni.2004.07.017
[18]. C. Pantaleão, A. Luchs. Câncer e modelos experimentais de tumores murinos. Ver Inst Adolfo Lutz. 2010. V. 69, n. 4, p. 439-45. http://periodicos.ses.sp.bvs.br/scielo.php?script=sci_arttext&pid=S0073-98552010000400001&lng=pt&nrm=iso
[19]. N. Sengupta, T.S. MacFie, T.T. MacDonald, D. Pennington, A.R. Silver. Cancer immuno editing and “spontaneus” tumor regression. Pathol Res Pract. 2010. v. 206, n. 1, p. 1-8.
[20]. S.I. Park, S.J. Kimm, L.K. McCauley, G.E. Gallick. Pre-Clinical Mouse Models of Human Prostate Cancer and their Utility in Drug Discovery. Curr Protoc Pharmacol. 2010 December 1; 51: 14.15–14.15.27. doi:10.1002/0471141755.ph1415s51.
[21]. M. Ittmann, J. Huang, E. Radaelli, P.Martin, S. Signoretti, R. Sullivan, B.W. Simons, J.M. Ward, B.D. Robinson, G.C. Chu, M. Loda, G. Thomas, A. Borowsky, R.D. Cardiff. Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Research Online. 2013. v.73, n. 9, p. 2718-3. disponívelem: https://cancerres.aacrjournals.org/content/73/9/2718.full-text.pdf
[22]. M.M. Shen, C. abate-shen. molecular genetics of prostate câncer: new prospects for old challenges. Genes dev. 2010. doi: 10.1101/gad.1965810.
[23]. D. Lin, H. Xue, Y. Wang, R. Wu, A. Watahiki, X. Dong, H. Cheng, A.W.Wyatt, C.C. Collins, P.W. Gout, Y. Wang. Next generation patient-derived prostate cancer xenograft models. Asian J Androl. 2014. v. 16, n. 3, p. 407-412. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023366/
[24]. Y. Wang, J.X. Wang, H. Xue, D. Lin, X. Dong, P.W. Gout, X. Gao, J. Pang. Subrenal capsule grafting technology in human câncer modeling and translational câncer research. Differentiation. 2015. 91:15–19. doi: 10.1016/j.diff.2015.10.012
[25]. N.M Navone, M.E. Labate, P. Troncoso, C.L. Pisters, A.C.V. Eschenbach, C.J. Logothetis. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. O Jornal de Urologia. 1999. v. 161, Edição 1, p. 304-308. PMID: 10037428
[26]. J. Pavese, I.M. Ogden, R.C. Bergan. An Orthotopic Murine Model of Human Prostate Cancer Metastasis. Journal of Visualized Experiments. p.1-9. 2013 doi: 10.3791/50873.
[27]. Y. Huang, C. Cheng, C. Zhang, Y. Zhang, M. Chen, D.W. Strand, M. Jiang. Advances in prostate cancer research models: From transgenic mice to tumor xenografting models. Asian Journal of Urology. 2016. 3:64-74. https://doi.org/10.1016/j.ajur.2016.02.004
Downloads
Published
2020-01-01
Issue
Section
Journal Articles
License
Copyright (c) 2020 Eliza Miranda Ramos, Antônio Carlos de Abreu, Evair Moisés de Lima Santiago, Gislaine Recaldes de Abreu, Marcelo Barbosa Neves, Rondon Ramalho
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
Ramos, E. M. ., de Abreu, A. C., de Lima Santiago, E. M. ., Recaldes de Abreu, G. ., Barbosa Neves, M. ., & Ramalho, R. (2020). A Murine experimental models in carcinogenesis studies are efficient?. International Journal for Innovation Education and Research, 8(1), 213-219. https://doi.org/10.31686/ijier.vol8.iss1.2153
Most read articles by the same author(s)
- Rondon Ramalho, Luiz Carlos Takita, Cesar Augusto Sobrinho, Marcel Arakaki Asato, Gabriely Lessa Sacht, Gunter Hans Filho, Rondon Tosta Ramalho, Ricardo Dutrra Aydos, Basal cell carcinoma - epidemiology, pathogenesis, pathology, and association with inflammation biomarkers. A review , International Journal for Innovation Education and Research: Vol. 8 No. 3 (2020): International Journal for Innovation Education and Research
- Eliza Miranda Ramos, Ernani Mendes da Fonseca Junior, Francisco José Mendes dos Reis, Igor Domingos de Souza, Alessandro Carvalho da Fonseca, Hugo Vieira Ramos, Proposal for the development and implementation of a Software for Monitoring Patients with Tuberculosis in Primary Care in the Pandemic: A Critical Analysis , International Journal for Innovation Education and Research: Vol. 9 No. 6 (2021): International Journal for Innovation Education and Research
- Marcelo Barbosa Neves, Alessandra de Figueiredo Gonçalves, Gabriela Rodrigues Alves, Luiz Carlos Takita, Letícia Silva Fagundes, Ana Keren dos Santos Rocha, Udenilson Nunes da Silva Junior, Julia Fogaça Toniello, Rondon Tosta Ramalho , Effect of physical exercise on colorectal cancer , International Journal for Innovation Education and Research: Vol. 9 No. 2 (2021): International Journal for Innovation Education and Research
- Eliza Miranda Ramos, Matheus Dullius de Lima, Jéssica Eloy Cunha Gonzalez, Gilberto Gonçalves Facco, Elaine S. de P. Melo, Hugo Vieira Ramos, Francisco José Mendes dos Reis, Igor Domingos de Souza, Valter Aragão do Nascimento, The Use of Vitamin D in The Infectious Process in The Hospital Period in Childhood Effective? , International Journal for Innovation Education and Research: Vol. 8 No. 5 (2020): International Journal for Innovation Education and Research
- Alessandro Carvalho da Fonseca, Hugo Vieira Ramos, Igor Domingos de Souza, Francisco José Mendes dos Reis, Eliza Miranda Ramos, The Challenge In The Use Of New Technologies Integrated To Health In The Treatment Of Covid-19 , International Journal for Innovation Education and Research: Vol. 8 No. 10 (2020): International Journal for Innovation Education and Research
- Eliza Miranda Ramos, Alessandro Carvalho da Fonseca, Hugo Vieira Ramos, Igor Domingos de Souza, Authentication in the use of health sensors to remote patients with covid-19 , International Journal for Innovation Education and Research: Vol. 8 No. 8 (2020): International Journal for Innovation Education and Research
- Eliza Miranda Ramos, Matheus Dullius de Lima, Jéssica Eloy Cunha Gonzalez, Gilberto Gonçalves Facco, Francisco José Mendes dos Reis, Elaine S. de P. Melo, Valter Aragão do Nascimento, Vitamin D3 Supplementation: An Option Associated with The Treatment of Multiple Sclerosis: , International Journal for Innovation Education and Research: Vol. 8 No. 5 (2020): International Journal for Innovation Education and Research
- César Augusto Sobrinho, Evair Moisés de Lima Santiago, Marcelo Barbosa Neves, Alessandra de Figueiredo Gonçalves, Eliza Miranda Ramos, Ricardo Dutra Aydos, Rondon Ramalho, Perspectives of the use of sulforaphane in animal model of colorectal carcinogenesis in Brazil , International Journal for Innovation Education and Research: Vol. 7 No. 12 (2019): International Journal for Innovation Education and Research
- Eliza Miranda Ramos, Dr. Gilberto Gonçalves Facco, Dr. Valter Aragão do Nascimento, Vitamin D, in the best clinic in autoimmune, inflammatory infectious and Demelinizing diseases , International Journal for Innovation Education and Research: Vol. 8 No. 4 (2020): International Journal for Innovation Education and Research
- Rondon Ramalho, Luiz Carlos Takita, Vanessa Gdla, Luiara Stefanelo Loro, Baltazar Dias Sanabria, Carlos Alberto Ferreira de Freitas, Antônio Carlos de Abreu, Cesar Augusto Sobrinho, A Basal cell carcinoma in the labial filter , International Journal for Innovation Education and Research: Vol. 7 No. 8 (2019): International Journal for Innovation Education and Research